Top Markets
Coin of the day
Jeisys Medical Inc. Jeisys Medical Inc.

Jeisys Medical Inc.

287410
Rank in Stocks #11661
Jeisys Medical Inc. is a company dedicated to the innovation and production of... Jeisys Medical Inc. is a company dedicated to the innovation and production of medical equipment, catering to a range of healthcare professionals including plastic surgeons, dermatologists, and other clinicians. Operating from its headquarters in Seoul, South Korea, the firm serves both its domestic market and international clients. Its comprehensive product line addresses various aesthetic and dermatological concerns, offering solutions for skin revitalization, firming, pigment correction, fat reduction, acne treatment, tattoo removal, and the management of scars and stretch marks. These advanced systems are branded under names such as ULTRAcel Q+, Cellec V, LIPOcel, AcGen, TRI-BEAM Premium, Edge ONE, SmoothCool, and ULTRAcel. The company distributes its offerings through an extensive network of partners. Jeisys Medical Inc. was established in 2001.
Share Price
$8.92
Last synced: 2024-10-18
Market Cap
$674.03M
Change (1 day)
-5.14%
Change (1 year)
0.00%
Country
KR
Trade Jeisys Medical Inc. (287410)

Category

P/S ratio for Jeisys Medical Inc. (287410)
P/S ratio as of August 2026 TTM: 6.81
According to Jeisys Medical Inc. latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 6.81. At the end of 2022 the company had a P/S ratio of 5.32.
P/S ratio history for Jeisys Medical Inc. from 2019 to 2026
P/S ratio at the end of each year
Year P/S Ratio Change
2026 (TTM) 6.81 22.35%
2023 5.57 4.73%
2022 5.32 -20.21%
2021 6.66 7.56%
2020 6.19 0.00%
2019 0.00 0.00%
P/S ratio for similar companies or competitors
Company P/S Ratio P/S Ratio Difference Country
4.13 -39.36%
US
5.03 -26.15%
US
2.78 -59.14%
IE
3.67 -46.16%
US
- -
DE